Health ❯ Public Health ❯ Disease Prevention

Influenza

Vaccination Vaccination Strategies Preventive Measures Vaccination Trends Vaccination Recommendations Influenza A H3N2 Pediatric Influenza Pediatric Health Immune Support H3N2

FDA Approves Moderna’s mFlusiva, First mRNA Flu Vaccine

Cleared for adults 50 or older, the authorization could speed seasonal vaccine updates by allowing quicker strain changes.

Russia Approves Adult Influenza Care Standard and Publishes Official Drug List

U.S. Pediatric Flu Deaths Rise to Nine as H3N2 Surge Strains Hospitals

Germany Confronts Early Flu Surge as Officials Assure Vaccine Supply

FDA-Recorded Recall Pulls 41,000 Walgreens Saline Nasal Sprays Over Bacterial Contamination

LA and Riverside Counties Report First Flu Deaths of 2025–26 Season

ECDC Warns of Early Flu Surge in Europe and Urges Immediate Vaccination

Oregon Health Care Worker Flu Vaccination Drops to 54%, State Warns of Patient Risk

WHO Sets 2026 Southern Hemisphere Trivalent Flu Vaccine Strains

Spanish Pediatric Societies Urge Nationwide Flu Vaccination for All Children Aged 6 Months to 17 Years

Russia Urges Flu Shots From Late September to Early November as Experts Eye Influenza A

U.S. Health Officials Urge Flu Shots Now Through October as Season Nears

AstraZeneca Launches FluMist Home Direct-to-Consumer Nasal Vaccine in 34 States

FDA Grants Full Approval to Moderna’s Pediatric COVID-19 Vaccine for At-Risk Children

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial

Flu Vaccination Rates for U.S. Children Drop to a Decade-Low

FDA Approves First At-Home Nasal Spray Flu Vaccine

CDC Funds Flu Vaccines for Farmworkers to Prevent Bird Flu Mutation